Application for Clinical Trials
Product Details
Title of Study: A Phase IIIB/IV Randomized Open-label Trial Comparing Dolutegravir with Predetermined Nucleosides Versus Recommended Standard of Care ART R regimens in Patients with HIV-1 Infection Failing First Line Therapy
Subtitle: D2EFT: Dolutegravir and Darunavir Evaluation in Adults Failing Therapy
Protocol; Version: NCT03017872; Version 2.0
Phase of Study: Phase 3;
Study Type: grant aided study
Approval Date:
Applicant Name: The Institute of Human Virology-IHVN
Address: Pent House, Maina Court, Plot 252, Herbert Macauly Way, CDB, Garki Way, Abuja
Date of Application: 2019-03-20
Applicant Name: The Institute of Human Virology-IHVN
Sponsor: University of New South Wales
Address of Sponsor: The Kirby Institute, University of New South Wales
Trial Sites: 1. University of Abuja Teaching Hospital, Gwagwalada, Area Council, Abuja 2. National Hospital Abuja, 265 Independence Avenue, CBD, Abuja
Product Type: Drug
Status of Approval: On-going
You are trying to load a table of an unknown type. Probably you did not activate the addon which is required to use this table type.